BNF:

not listed

Status:

Grey

Decision Date:

December 2016

Comments

GREY: For the treatment of recurrent bacterial vaginosis, as a second line option after treatment failure and or intolerance to metronidazole.

Grey Drug Classifications

• 1: Lack of data on effectiveness compared with standard therapy
• 5: Less cost-effective than current standard therapy

search again